Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - P/B ratio
P/B ratio as of May 2024 : 2.03
According to Prestige Consumer Healthcare's latest financial reports the company has a price-to-book ratio of 2.03.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Prestige Consumer Healthcare - P/B ratio (from 2005 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.90 | 3.26% |
| 2022-12-31 | 1.84 | -8.17% |
| 2021-12-31 | 2.00 | 51.58% |
| 2020-12-31 | 1.32 | -24.97% |
| 2019-12-31 | 1.76 | 35.67% |
| 2018-12-31 | 1.30 | -32.96% |
| 2017-12-31 | 1.93 | -43.89% |
| 2016-12-31 | 3.45 | -8.47% |
| 2015-12-31 | 3.77 | 26.44% |
| 2014-12-31 | 2.98 | -12.56% |
| 2013-12-31 | 3.41 | 52.48% |
| 2012-12-31 | 2.23 | 57.91% |
| 2011-12-31 | 1.42 | -16.18% |
| 2010-12-31 | 1.69 | 39.46% |
| 2009-12-31 | 1.21 | 15.74% |
| 2008-12-31 | 1.05 | 31.25% |
| 2007-12-31 | 0.7969 | -46.53% |
| 2006-12-31 | 1.49 | -3.51% |
| 2005-12-31 | 1.54 | |
| 2004-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.30 | 161.68% | 🇺🇸 USA |
 Procter & Gamble PG | 7.87 | 288.42% | 🇺🇸 USA |
 Novartis NVS | 5.27 | 160.08% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.84 | -9.43% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.70 | 131.87% | 🇺🇸 USA |
 Clorox CLX | 66.7 | 3,191.77% | 🇺🇸 USA |
 CVS Health CVS | 0.9738 | -51.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.54 | 173.17% | 🇬🇧 UK |
 Rite Aid
RAD | -0.0187 | -100.92% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | 0.8915 | -56.01% | 🇮🇱 Israel |